| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/23/2011 | US20110152258 Compounds and Methods for Kinase Modulation, and Indications Therefor |
| 06/23/2011 | US20110152247 Benzoxazepine compounds, their preparation and use |
| 06/23/2011 | US20110152242 2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists |
| 06/23/2011 | US20110152241 Novel compounds as receptor modulators with therapeutic utility |
| 06/23/2011 | US20110152240 Pyrazolopyrimidines and related heterocycles as ck2 inhibitors |
| 06/23/2011 | US20110152238 Pharmaceutical compounds |
| 06/23/2011 | US20110152236 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 06/23/2011 | US20110152228 Sprayable pharmaceutical compositions comprising a corticoid and an oily phase |
| 06/23/2011 | US20110152227 Deuterium labelled derivatives of 3-(2-hydroxy-5-methyphenyl)-n,n-diisopropyl-3-phenylpropylamine and methods of use thereof |
| 06/23/2011 | US20110152224 Myeloperoxidase, a risk indicator for cardiovascular disease |
| 06/23/2011 | US20110152221 PAK1 Agonists and Methods of Use |
| 06/23/2011 | US20110152217 Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2]oxaborol-1-ol |
| 06/23/2011 | US20110152209 Core 2 GlcNAc-T Inhibitors |
| 06/23/2011 | US20110152194 Chimeric natriuretic polypeptides and methods for inhibiting cardiac remodeling |
| 06/23/2011 | US20110152191 Natriuretic polypeptides with unique pharmacologic profiles |
| 06/23/2011 | US20110152171 Histamine binding protein |
| 06/23/2011 | US20110152169 Sparc anti-inflammatory activity and uses thereof |
| 06/23/2011 | US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 06/23/2011 | US20110151030 Compositions for alleviating inflammation and oxidative stress in a mammal |
| 06/23/2011 | US20110151005 Methods and means for soft tissue engineering |
| 06/23/2011 | US20110151000 Nitric oxide-releasing compositions, devices and methods |
| 06/23/2011 | US20110150980 Cgrp analog |
| 06/23/2011 | US20110150978 Ph-sensitive block copolymer forming polyionic complex micelles and drug or protein carrier using the same |
| 06/23/2011 | US20110150894 Methods of modulating angiogenesis via trpv4 |
| 06/23/2011 | US20110150888 Anti-hepcidin antibodies and methods of use |
| 06/23/2011 | US20110150879 Specific depletion of cd4+ t cells |
| 06/23/2011 | US20110150875 Egf-a domain-mediated modulation of pcks9 for treating lipid disorders |
| 06/23/2011 | US20110150873 Anti-inflammatory compositions and combinations |
| 06/23/2011 | US20110150864 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators |
| 06/23/2011 | US20110150862 Inhibitors of stim1 for the treatment of cardiovascular disorders |
| 06/23/2011 | US20110150853 Mycotoxin-reducing composition |
| 06/23/2011 | US20110150833 Benzopyrans and analogs as rho kinase inhibitors |
| 06/23/2011 | US20110150831 Novel naphthyridine derivatives and the use thereof as kinase inhibitors |
| 06/23/2011 | US20110150764 Stroke-tageting peptide and use thereof |
| 06/23/2011 | US20110150763 Triazine derivatives and their therapeutical applications |
| 06/23/2011 | US20110150757 Compounds for inhibiting ksp kinesin activity |
| 06/23/2011 | CA2784788A1 Methods and compositions for treating peripheral vascular disease |
| 06/23/2011 | CA2784710A1 Oxadiazole derivative having endothelial lipase inhibitory activity |
| 06/23/2011 | CA2784566A1 Heterocyclic compounds and their uses |
| 06/23/2011 | CA2784297A1 Compositions and methods related to mirna in diabetic conditions |
| 06/23/2011 | CA2784010A1 Novel solvates of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate |
| 06/23/2011 | CA2782967A1 Traditional chinese drug comprising danshen extracts and sanqi extracts and use thereof |
| 06/23/2011 | CA2782601A1 Novel antiplatelet agent |
| 06/23/2011 | CA2781186A1 New phenylhydrazone derivatives and their use as pharmaceuticals |
| 06/23/2011 | CA2780290A1 Mk2 inhibitors |
| 06/22/2011 | EP2336359A1 1L1RL-1 as a cardiovascular disease marker and therapeutic target |
| 06/22/2011 | EP2336321A1 Ox2 receptor homolog |
| 06/22/2011 | EP2336301A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336300A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336299A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336297A2 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 06/22/2011 | EP2336145A1 Antisense modulation of apolipoprotein B expression |
| 06/22/2011 | EP2336133A1 Purine analogs having HSP90-inhibiting activity |
| 06/22/2011 | EP2336111A1 Heterocyclic inhibitors of p38 |
| 06/22/2011 | EP2335711A2 Extract of hancornia speciosa and pharmaceutical composition thereof |
| 06/22/2011 | EP2335710A1 Electron irradiated physiologically isotonic solution, electron irradiation device for electron irradiated physiologically isotonic solution, and organ storage container |
| 06/22/2011 | EP2335709A1 Insulin resistance improving agent |
| 06/22/2011 | EP2335695A1 Use of aminapthone for the preparation of a medicament for treating arteriophaties |
| 06/22/2011 | EP2335694A1 Thyroid hormone analogs and methods of use. |
| 06/22/2011 | EP2335494A1 Method for concentrating lipid |
| 06/22/2011 | EP2334682A1 Pyrrolo [ 1, 2 -b] pyridazine derivatives and their use as hif modulators |
| 06/22/2011 | EP2334668A1 Process for preparing olmesartan medoxomil intermediate |
| 06/22/2011 | EP2334651A2 Dual-acting antihypertensive agents |
| 06/22/2011 | EP2334324A2 Bbeta (15-42) and its analogues combined with cyclosporine for treatment of reperfusion injury |
| 06/22/2011 | EP2334295A1 Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same |
| 06/22/2011 | EP2334293A2 Compositions comprising polyhydroxyltate fatty alcohol derivatives and the therapeutic uses |
| 06/22/2011 | EP1616856B1 Novel transcriptional factor, process for producing the same and use thereof |
| 06/22/2011 | EP1324771B1 Therapeutic and tolerance inducing antibodies |
| 06/22/2011 | CN1984905B Constrained himbacine analogs as thrombin receptor antagonists |
| 06/22/2011 | CN1903364B Medicine composition containing inhibitor of angiotonase and phenoxy acid compounds |
| 06/22/2011 | CN1883537B Compound Chinese medicinal preparation for treating hypertension and hyperlipemia and preparation method thereof |
| 06/22/2011 | CN1874778B Pharmaceutical formulation comprising a pyrimidine-A-one derivative coated with an enteric polymer |
| 06/22/2011 | CN1447819B Human CYR 61 |
| 06/22/2011 | CN102105789A Brown adipocyte progenitors in human skeletal muscle |
| 06/22/2011 | CN102105452A Substituted carbinol compound having cyclic linker |
| 06/22/2011 | CN102105448A Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states |
| 06/22/2011 | CN102105161A Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 06/22/2011 | CN102105154A Preparation for oral administration comprising water-extracted chondroitin sulfate and quercetin glycoside |
| 06/22/2011 | CN102102060A Production process for red-rooted salvia root yellow wine |
| 06/22/2011 | CN102101880A Preparation method and application of radix astragali saponin |
| 06/22/2011 | CN102101863A Novel epoxy thiazone compounds and preparation method and application thereof |
| 06/22/2011 | CN102101836A New crystal form of S-oxiracetam and preparation method thereof |
| 06/22/2011 | CN102100913A Target spot and medicine for treating cerebral injury |
| 06/22/2011 | CN102100904A Reduced glutathione percutaneous absorption preparation and preparation method thereof |
| 06/22/2011 | CN102100902A Counterflow cold effervescent tablets |
| 06/22/2011 | CN102100899A Preparation technology of new integrative formulation of prepared common monkshood daughter root decoction for regulating middle |
| 06/22/2011 | CN102100889A Preparation technology of new integrative formulation of spleen-returning decoction |
| 06/22/2011 | CN102100886A Technology and method for preparing novel combined formulation of relieving-edema decoction |
| 06/22/2011 | CN102100884A Preparation technology of new integrative formulation of minor green-blue dragon decoction |
| 06/22/2011 | CN102100883A Preparation technology of new integrative formulation of middle regulating decoction |
| 06/22/2011 | CN102100875A Process method for microwave assistant supercritical extraction of active ingredients of curcuma |
| 06/22/2011 | CN102100873A Chinese patent medicine for treating heart cerebrovascular diseases and preparation method thereof |
| 06/22/2011 | CN102100833A Drug composition for treating heart cerebrovascular diseases as well as preparation method and application thereof |
| 06/22/2011 | CN102100827A External-use ointment for treating hemorrhoids |
| 06/22/2011 | CN102100821A Medicinal cigarette external surface liniment for treating hemorrhoids, and preparation method and application thereof |
| 06/22/2011 | CN102100813A Preparation technology of new integrative formulation of poria five powder and production method thereof |
| 06/22/2011 | CN102100808A Chinese medicinal preparation for treating headache |
| 06/22/2011 | CN102100807A Chinese medicine composition for regulating qi, widening chest and relieving pain as well as detection method thereof |
| 06/22/2011 | CN102100800A Traditional Chinese medicine for treating high blood pressure medicine and preparation method thereof |
| 06/22/2011 | CN102100785A Preparation technique for xiao chengqi decoction in a novel formed formulation and production method thereof |